MaaT Pharma SA
MaaT Pharma SA (MAAT.PA) Company Profile & Overview
Explore MaaT Pharma SA’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.
MaaT Pharma SA (MAAT.PA) Company Profile & Overview
MaaT Pharma SA, a clinical stage company, engages in the research and development of microbiome biotherapies for the treatment of solid cancer tumors. Its products pipeline includes MaaT013 that has completed phase 2 clinical trials for the treatment of acute graft versus host diseases, as well as in preclinical trials to treat melanoma; MaaT033, which is in phase 1b clinical trials for the improvement of survival in patients with acute myeloid leukemia or other liquid tumors receiving allogeneic hematopoietic stem cell transplantation; and MaaT03X for the treatment of solid tumors. The company was incorporated in 2014 and is headquartered in Lyon, France.